Преглед Radovi istraživača / Researchers' publications тема: "IL-17"
Приказ резултата 1-14 од 14
-
Combined effect of IL-17 and blockade of nitric oxide biosynthesis on haematopoiesis in mice
(Wiley, Hoboken, 2010) -
Effect of IL-17 on in vitro hematopoietic progenitor cells growth and cytokine release in normal and post-irradiated murine bone marrow
(Taylor & Francis Ltd, Abingdon, 2001) -
Effects of il-17 on erythroid progenitors growth: involvement of mapks and gata transcription factors
(Biolife Sas, Silva Marina (Te), 2012) -
Effects of IL-17 on functional activity of peripheral blood cells / Efekti IL-17 na funkcionalnu aktivnost ćelija periferne krvi
(Univerzitet u Beogradu - Fakultet veterinarske medicine, Beograd, 2004) -
Hematopoietic changes and altered reactivity to IL-17 in Syphacia obvelata-infected mice
(Elsevier Ireland Ltd, Clare, 2006) -
IL-17 and FGF signaling involved in mouse mesenchymal stem cell proliferation
(Springer, New York, 2011) -
In vitro effects of IL-17 on angiogenic properties of endothelial cells in relation to oxygen levels
(Wiley, Hoboken, 2013) -
Interleukin 17 inhibits myogenic and promotes osteogenic differentiation of C2C12 myoblasts by activating ERK1,2
(Elsevier, Amsterdam, 2012) -
Interleukin-17 modulates myoblast cell migration by inhibiting urokinase type plasminogen activator expression through p38 mitogen-activated protein kinase
(Pergamon-Elsevier Science Ltd, Oxford, 2013) -
Low O-2 concentrations enhance the positive effect of IL-17 on the maintenance of erythroid progenitors during co-culture of CD34+and mesenchymal stem cells
(John Libbey Eurotext Ltd, Montrouge, 2009) -
p38 MAPK signaling mediates IL-17-induced nitric oxide synthase expression in bone marrow cells
(Taylor & Francis Ltd, Abingdon, 2009) -
The potential of interleukin-17 to mediate hematopoietic response
(Humana Press Inc, Totowa, 2012) -
Syphacia obvelata modifies mitogen-activated protein kinases and nitric oxide synthases expression in murine bone marrow cells
(Elsevier Ireland Ltd, Clare, 2010)